Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Fda approval date for maci?

See the DrugPatentWatch profile for maci

FDA Approval Date for Macitentan (“Maci”)
The FDA granted approval for macitentan (brand‑name Macitentan) on September 9, 2011.
It was approved as a once‑daily oral therapy for the treatment of pulmonary arterial hypertension (PAH).

Source: FDA’s Drug Approval History and the “Macitentan” FDA approval page.



Other Questions About Maci :

armodafinil prix pharmacie